BATS BZX Real-Time Price
As of 3:22pm ET
| +0.48 / +3.44%|
The 8 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 14.50, with a high estimate of 30.00 and a low estimate of 11.00. The median estimate represents a +0.42% increase from the last price of 14.44.
The current consensus among 8 polled investment analysts is to Hold stock in Clovis Oncology Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.